Renaissance Technologies’s OncoSec Medical Incorporated ONCS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-24,179
| Closed | -$41K | – | 4594 |
|
|
2022
Q4 | $41K | Buy |
24,179
+21,115
| +689% | +$35.8K | ﹤0.01% | 3842 |
|
|
2022
Q3 | $33K | Sell |
3,064
-250
| -8% | -$2.69K | ﹤0.01% | 3833 |
|
|
2022
Q2 | $54K | Buy |
3,314
+1,087
| +49% | +$17.7K | ﹤0.01% | 3987 |
|
|
2022
Q1 | $56K | Sell |
2,227
-9,108
| -80% | -$229K | ﹤0.01% | 3894 |
|
|
2021
Q4 | $239K | Buy |
11,335
+6,612
| +140% | +$139K | ﹤0.01% | 3442 |
|
|
2021
Q3 | $221K | Sell |
4,723
-13,073
| -73% | -$612K | ﹤0.01% | 3171 |
|
|
2021
Q2 | $1.1M | Buy |
17,796
+2,309
| +15% | +$143K | ﹤0.01% | 2626 |
|
|
2021
Q1 | $1.63M | Buy |
15,487
+991
| +7% | +$104K | ﹤0.01% | 2350 |
|
|
2020
Q4 | $2.06M | Sell |
14,496
-3,810
| -21% | -$541K | ﹤0.01% | 2100 |
|
|
2020
Q3 | $1.36M | Buy |
18,306
+2,167
| +13% | +$161K | ﹤0.01% | 2335 |
|
|
2020
Q2 | $728K | Buy |
16,139
+5,340
| +49% | +$241K | ﹤0.01% | 2708 |
|
|
2020
Q1 | $302K | Buy |
10,799
+1,775
| +20% | +$49.6K | ﹤0.01% | 2981 |
|
|
2019
Q4 | $359K | Buy |
9,024
+4,857
| +117% | +$193K | ﹤0.01% | 3018 |
|
|
2019
Q3 | $181K | Buy |
+4,167
| New | +$181K | ﹤0.01% | 3171 |
|
|
2018
Q1 | – | Sell |
-760
| Closed | -$272K | – | 3698 |
|
|
2017
Q4 | $272K | Buy |
+760
| New | +$272K | ﹤0.01% | 3048 |
|
|
2017
Q1 | – | Sell |
-432
| Closed | -$117K | – | 3520 |
|
|
2016
Q4 | $117K | Sell |
432
-284
| -40% | -$76.9K | ﹤0.01% | 3085 |
|
|
2016
Q3 | $269K | Buy |
716
+156
| +28% | +$58.6K | ﹤0.01% | 2989 |
|
|
2016
Q2 | $202K | Buy |
560
+363
| +184% | +$131K | ﹤0.01% | 3047 |
|
|
2016
Q1 | $111K | Buy |
+197
| New | +$111K | ﹤0.01% | 3198 |
|